Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Patient had multiple medications scheduled including zofran & morphine. As pt its getting ready to go to CT scan tetanus vaccine administered via IV route instead of IM how it was ordered. Error was identify immediately after administration. Patient assessed and remained stable with no acute distress noted. Vital signs within normal limits. NP notified at this time & recommended calling poison control. Poison control was called & spoke to [withheld], per their recommendation to keep patient to be monitored 6 hours along with CBC & BMP re check at that time post Tdap IV administration. Per poison control patient to be monitored for potential adverse effects including hypersensitivity reaction, anaphylaxis reaction. NP made aware. Vitals signs were reassesses and remain stable. No complications noted at injection site, no complaints of pain, burning or swelling.